Economic evaluation of human papilloma virus vaccination in the European Union: a critical reviewArchived
The authors performed a literature review of all economic evaluations (EEs) of HPV vaccines conducted in EU countries and published in English from January 2007 to June 2010. EEs were classified and compared according to their model, the economic variables used, the modelling techniques and whether or not they had financial backing from vaccine manufacturers.
Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: A cervical cancer screening based studyArchived
Similar to other European countries, cervical infection with HPV-16, the HPV type with the strongest oncogenic potential, were most common both overall and among women with cervical disease.
Detection of human papillomavirus DNA in urine. A review of the literatureArchived
HPV DNA detection in urine is a feasible practice and a useful tool in future research; however, the available studies dealing on the topic appear too diverse in their setup and applied methodology to draw conclusive statements
EIW 2015 at ECDC
On the occasion of the tenth anniversary of European Immunization Week, ECDC is releasing a new complement of data, tools, blogs and updates to support public health authorities in their work against vaccine preventable diseases.
ECDC guidance on HPV vaccination: Focus on reaching all girlsArchived
Today, ECDC publishes an update to its 2008 Guidance on human papillomavirus (HPV) vaccines in Europe. The update follows the introduction of vaccination programmes in 19 European countries and new evidence from research studies over the past four years.
Evidence of efficacy of HPV vaccines in males
What is the evidence on the efficacy of the HPV vaccines in males?